Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

A randomized controlled trial of group cognitive behavioral therapy for Chinese breast cancer patients with major depression

A randomized controlled trial of group cognitive behavioral therapy for Chinese breast cancer patients with major depression JOURNAL OF PSYCHOSOMATIC OBSTETRICS AND GYNECOLOGY Qiu, J., Chen, W., Gao, X., Xu, Y., Tong, H., Yang, M., Xiao, Z., Yang, M. 2013; 34 (2): 60–67

Abstract

This study aims to evaluate the effects of Group Cognitive Behavioral Therapy (GCBT) in treating major depression in Chinese women with breast cancer.Sixty-two breast cancer patients diagnosed with major depression were randomly assigned to GCBT group (N?=?31) or a waiting list control group provided with an educational booklet (N?=?31). The primary outcome measure was the 17-Item Hamilton Depression Rating Scale (17-HAMD). The second outcome measures were Self-Rating Anxiety Scale, Functional Assessment of Cancer Therapy - Breast and Self-Esteem Scale (SES). Assessments were carried out at completion of the study and six-month afterwards.Patients in the GCBT group had a significant reduction in the 17-HAMD mean score by 9 points (p??0.05).The results of this trial suggest that GCBT is effective for treating major depression, as well as for improving QoL and self-esteem in breast cancer patients.Chictr.org ChiCTR-TRC-11001689.

View details for DOI 10.3109/0167482X.2013.766791

View details for Web of Science ID 000319748300002

View details for PubMedID 23646866